Showing results (1121-1130 of 6,916) with videos related to
Sort By:
Pageof 692
Rheumatology International|December 23, 2016
Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestationsUfuk İlgen, Müçteba Enes Yayla, Nurşen DüzgünRheumatology International|December 26, 2016
Physical activity but not sedentary activity is reduced in primary Sjögren's syndromeWan-Fai Ng, Ariana Miller, Simon J Bowman, et al.Rheumatology International|January 8, 2017
Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health IndexMarco Di Carlo, Valentina Lato, Andrea Di Matteo, et al.Rheumatology International|April 22, 2014
Low vitamin D level is not associated with increased incidence of rheumatoid arthritisJonida Cote, Andrea Berger, Lester H Kirchner, et al.Rheumatology International|April 22, 2014
Soluble TNF receptors are produced at sites of inflammation and are inversely associated with self-reported symptoms (WOMAC) in knee osteoarthritisAdriano Prado Simão, Tássio Málber de Oliveira Almeida, Vanessa Amaral Mendonça, et al.Rheumatology International|April 15, 2014
Assessment of the effectiveness of interferential current therapy and TENS in the management of carpal tunnel syndrome: a randomized controlled studyIrfan Koca, Ahmet Boyaci, Ahmet Tutoglu, et al.Rheumatology International|April 15, 2014
Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysisYoung Ho Lee, Sang-Cheol Bae, Gwan Gyu SongRheumatology International|May 3, 2014
Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositisSlavica R Pavlov-Dolijanovic, Nada Z Vujasinovic Stupar, Nikola Gavrilov, et al.Rheumatology International|April 3, 2014
Network meta-analysis for comparing treatment effects of multiple interventions: an introductionFerrán Catalá-López, Aurelio Tobías, Chris Cameron, et al.Rheumatology International|January 1, 1989
Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosusA J Swaak, A van Rooyen, L A AardenPageof 692